Comparative Impact of PD-1 and PD-L1 Inhibitors on Advanced Esophageal or Gastric/Gastroesophageal Junction Cancer Treatment: A Systematic Review and Meta-Analysis

Programmed death 1 (PD-1) and PD ligand 1 (PD-L1) inhibitors have demonstrated varying effectiveness in treating esophageal or gastric/gastroesophageal junction (G/GEJ) cancer. Hence, this systematic review and meta-analysis evaluated the efficacy and safety of anti-PD-1/PD-L1 treatment in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, SuA, Kim, Eunyoung, Lee, Heeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397221/
https://www.ncbi.nlm.nih.gov/pubmed/34441907
http://dx.doi.org/10.3390/jcm10163612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397221/
https://www.ncbi.nlm.nih.gov/pubmed/34441907
http://dx.doi.org/10.3390/jcm10163612

Ejemplares similares